<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">38825590</PMID><DateCompleted><Year>2024</Year><Month>06</Month><Day>02</Day></DateCompleted><DateRevised><Year>2024</Year><Month>06</Month><Day>05</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Electronic">2045-2322</ISSN><JournalIssue CitedMedium="Internet"><Volume>14</Volume><Issue>1</Issue><PubDate><Year>2024</Year><Month>Jun</Month><Day>02</Day></PubDate></JournalIssue><Title>Scientific reports</Title><ISOAbbreviation>Sci Rep</ISOAbbreviation></Journal><ArticleTitle>The influence of endurance exercise training on myocardial fibrosis and arrhythmogenesis in a coxsackievirus B3 myocarditis mouse model.</ArticleTitle><Pagination><StartPage>12653</StartPage><MedlinePgn>12653</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">12653</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1038/s41598-024-61874-x</ELocationID><Abstract><AbstractText>Nonischaemic myocardial fibrosis is associated with cardiac dysfunction, malignant arrhythmias and sudden cardiac death. In the absence of a specific aetiology, its finding as late gadolinium enhancement (LGE) on cardiac magnetic resonance imaging is often attributed to preceding viral myocarditis. Athletes presenting with ventricular arrhythmias often have nonischaemic LGE. Previous studies have demonstrated an adverse effect of exercise on the course of acute viral myocarditis. In this study, we have investigated, for the first time, the impact of endurance training on longer-term outcomes such as myocardial fibrosis and arrhythmogenicity in a murine coxsackievirus B3 (CVB)-induced myocarditis model. Male C57BL/6J mice (n = 72) were randomly assigned to 8 weeks of forced treadmill running (EEX) or no exercise (SED). Myocarditis was induced 2 weeks later by a single intraperitoneal injection with CVB, versus vehicle in the controls (PBS). In a separate study, mice (n = 30) were subjected to pretraining for 13 weeks (preEEX), without continuation of exercise during myocarditis. Overall, continuation of exercise resulted in a milder clinical course of viral disease, with less weight loss and better preserved running capacity. CVB-EEX and preEEX-CVB mice tended to have a lower mortality rate. At sacrifice (i.e. 6 weeks after inoculation), the majority of virus was cleared from the heart. Histological assessment demonstrated prominent myocardial inflammatory infiltration and cardiomyocyte loss in both CVB groups. Inflammatory lesions in the CVB-EEX group contained higher numbers of pro-inflammatory cells (iNOS-reactive macrophages and CD8<sup>+</sup> T lymphocytes) compared to these in CVB-SED. Treadmill running during myocarditis increased interstitial fibrosis [82.4% (CVB-EEX) vs. 56.3% (CVB-SED); P = 0.049]. Additionally, perivascular and/or interstitial fibrosis with extensive distribution was more likely to occur with exercise [64.7% and 64.7% (CVB-EEX) vs. 50% and 31.3% (CVB-SED); P = 0.048]. There was a numerical, but not significant, increase in the number of scars per cross-section (1.9 vs. 1.2; P = 0.195), with similar scar distribution and histological appearance in CVB-EEX and CVB-SED. In vivo electrophysiology studies did not induce sustained monomorphic ventricular tachycardia, only nonsustained (usually polymorphic) runs. Their cumulative beat count and duration paralleled the increased fibrosis between CVB-EEX and CVB-SED, but the difference was not significant (P = 0.084 for each). Interestingly, in mice that were subjected to pretraining only without continuation of exercise during myocarditis, no differences between pretrained and sedentary mice were observed at sacrifice (i.e. 6 weeks after inoculation and training cessation) with regard to myocardial inflammation, fibrosis, and ventricular arrhythmogenicity. In conclusion, endurance exercise during viral myocarditis modulates the inflammatory process with more pro-inflammatory cells and enhances perivascular and interstitial fibrosis development. The impact on ventricular arrhythmogenesis requires further exploration.</AbstractText><CopyrightInformation>© 2024. The Author(s).</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y" EqualContrib="Y"><LastName>Favere</LastName><ForeName>Kasper</ForeName><Initials>K</Initials><Identifier Source="ORCID">0000-0003-1848-3701</Identifier><AffiliationInfo><Affiliation>Laboratory of Physiopharmacology, GENCOR, University of Antwerp, 2610, Antwerp, Belgium. Kasper.Favere@uantwerpen.be.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Research Group Cardiovascular Diseases, GENCOR, University of Antwerp, 2610, Antwerp, Belgium. Kasper.Favere@uantwerpen.be.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Cardiology, Antwerp University Hospital, 2650, Antwerp, Belgium. Kasper.Favere@uantwerpen.be.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Internal Medicine, Ghent University, 9000, Ghent, Belgium. Kasper.Favere@uantwerpen.be.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y" EqualContrib="Y"><LastName>Van Hecke</LastName><ForeName>Manon</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Translational Cell and Tissue Research, Department of Imaging and Pathology, University of Leuven, 3000, Leuven, Belgium.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Eens</LastName><ForeName>Sander</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Laboratory of Physiopharmacology, GENCOR, University of Antwerp, 2610, Antwerp, Belgium.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Research Group Cardiovascular Diseases, GENCOR, University of Antwerp, 2610, Antwerp, Belgium.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Bosman</LastName><ForeName>Matthias</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Laboratory of Physiopharmacology, GENCOR, University of Antwerp, 2610, Antwerp, Belgium.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Delputte</LastName><ForeName>Peter L</ForeName><Initials>PL</Initials><AffiliationInfo><Affiliation>Laboratory of Microbiology, Parasitology and Hygiene, University of Antwerp, 2610, Antwerp, Belgium.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>De Sutter</LastName><ForeName>Johan</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Department of Internal Medicine, Ghent University, 9000, Ghent, Belgium.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Fransen</LastName><ForeName>Erik</ForeName><Initials>E</Initials><AffiliationInfo><Affiliation>Centre for Medical Genetics, University of Antwerp, 2610, Antwerp, Belgium.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Roskams</LastName><ForeName>Tania</ForeName><Initials>T</Initials><AffiliationInfo><Affiliation>Translational Cell and Tissue Research, Department of Imaging and Pathology, University of Leuven, 3000, Leuven, Belgium.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Guns</LastName><ForeName>Pieter-Jan</ForeName><Initials>PJ</Initials><AffiliationInfo><Affiliation>Laboratory of Physiopharmacology, GENCOR, University of Antwerp, 2610, Antwerp, Belgium.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Heidbuchel</LastName><ForeName>Hein</ForeName><Initials>H</Initials><AffiliationInfo><Affiliation>Research Group Cardiovascular Diseases, GENCOR, University of Antwerp, 2610, Antwerp, Belgium.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Cardiology, Antwerp University Hospital, 2650, Antwerp, Belgium.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>G099222N</GrantID><Agency>Fonds Wetenschappelijk Onderzoek</Agency><Country /></Grant><Grant><GrantID>G099222N</GrantID><Agency>Fonds Wetenschappelijk Onderzoek</Agency><Country /></Grant><Grant><GrantID>1S33720N</GrantID><Agency>Fonds Wetenschappelijk Onderzoek</Agency><Country /></Grant><Grant><GrantID>G099222N</GrantID><Agency>Fonds Wetenschappelijk Onderzoek</Agency><Country /></Grant><Grant><GrantID>G099222N</GrantID><Agency>Fonds Wetenschappelijk Onderzoek</Agency><Country /></Grant><Grant><GrantID>G099222N</GrantID><Agency>Fonds Wetenschappelijk Onderzoek</Agency><Country /></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2024</Year><Month>06</Month><Day>02</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Sci Rep</MedlineTA><NlmUniqueID>101563288</NlmUniqueID><ISSNLinking>2045-2322</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000818" MajorTopicYN="N">Animals</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D009205" MajorTopicYN="Y">Myocarditis</DescriptorName><QualifierName UI="Q000821" MajorTopicYN="N">virology</QualifierName><QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D051379" MajorTopicYN="N">Mice</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D010805" MajorTopicYN="Y">Physical Conditioning, Animal</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D004195" MajorTopicYN="Y">Disease Models, Animal</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D001145" MajorTopicYN="Y">Arrhythmias, Cardiac</DescriptorName><QualifierName UI="Q000209" MajorTopicYN="N">etiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D005355" MajorTopicYN="Y">Fibrosis</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D029822" MajorTopicYN="Y">Enterovirus B, Human</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D003384" MajorTopicYN="Y">Coxsackievirus Infections</DescriptorName><QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName><QualifierName UI="Q000150" MajorTopicYN="N">complications</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008810" MajorTopicYN="Y">Mice, Inbred C57BL</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D009206" MajorTopicYN="N">Myocardium</DescriptorName><QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000076663" MajorTopicYN="N">Endurance Training</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Arrhythmogenesis</Keyword><Keyword MajorTopicYN="N">Exercise</Keyword><Keyword MajorTopicYN="N">Inflammation</Keyword><Keyword MajorTopicYN="N">Myocardial fibrosis</Keyword><Keyword MajorTopicYN="N">Scarring</Keyword><Keyword MajorTopicYN="N">Viral myocarditis</Keyword></KeywordList><CoiStatement>The authors declare no competing interests.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2023</Year><Month>12</Month><Day>29</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2024</Year><Month>5</Month><Day>10</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2024</Year><Month>6</Month><Day>3</Day><Hour>0</Hour><Minute>43</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2024</Year><Month>6</Month><Day>3</Day><Hour>0</Hour><Minute>42</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2024</Year><Month>6</Month><Day>2</Day><Hour>23</Hour><Minute>2</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2024</Year><Month>6</Month><Day>2</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">38825590</ArticleId><ArticleId IdType="pmc">PMC11144711</ArticleId><ArticleId IdType="doi">10.1038/s41598-024-61874-x</ArticleId><ArticleId IdType="pii">10.1038/s41598-024-61874-x</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Schnell F, et al. Subepicardial delayed gadolinium enhancement in asymptomatic athletes: let sleeping dogs lie? Br. J. Sports Med. 2016;50:111–117. doi: 10.1136/bjsports-2014-094546.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bjsports-2014-094546</ArticleId><ArticleId IdType="pubmed">26224114</ArticleId></ArticleIdList></Reference><Reference><Citation>Zorzi A, et al. Nonischemic left ventricular scar as a substrate of life-threatening ventricular arrhythmias and sudden cardiac death in competitive athletes. Circ. Arrhythm. Electrophysiol. 2016 doi: 10.1161/CIRCEP.116.004229.</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/CIRCEP.116.004229</ArticleId><ArticleId IdType="pmc">PMC4956679</ArticleId><ArticleId IdType="pubmed">27390211</ArticleId></ArticleIdList></Reference><Reference><Citation>Fung G, Luo H, Qiu Y, Yang D, McManus B. Myocarditis. Circ. Res. 2016;118:496–514. doi: 10.1161/CIRCRESAHA.115.306573.</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/CIRCRESAHA.115.306573</ArticleId><ArticleId IdType="pubmed">26846643</ArticleId></ArticleIdList></Reference><Reference><Citation>Daniels CJ, et al. Prevalence of clinical and subclinical myocarditis in competitive athletes with recent SARS-CoV-2 infection: Results from the big ten COVID-19 cardiac registry. JAMA Cardiol. 2021;6:1078–1087. doi: 10.1001/jamacardio.2021.2065.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jamacardio.2021.2065</ArticleId><ArticleId IdType="pmc">PMC8160916</ArticleId><ArticleId IdType="pubmed">34042947</ArticleId></ArticleIdList></Reference><Reference><Citation>Tschope C, Cooper LT, Torre-Amione G, Van Linthout S. Management of myocarditis-related cardiomyopathy in adults. Circ. Res. 2019;124:1568–1583. doi: 10.1161/CIRCRESAHA.118.313578.</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/CIRCRESAHA.118.313578</ArticleId><ArticleId IdType="pubmed">31120823</ArticleId></ArticleIdList></Reference><Reference><Citation>Cocker MS, Abdel-Aty H, Strohm O, Friedrich MG. Age and gender effects on the extent of myocardial involvement in acute myocarditis: A cardiovascular magnetic resonance study. Heart. 2009;95:1925–1930. doi: 10.1136/hrt.2008.164061.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/hrt.2008.164061</ArticleId><ArticleId IdType="pubmed">19710029</ArticleId></ArticleIdList></Reference><Reference><Citation>Prior DL, La Gerche A. The athlete's heart. Heart (Br. Cardiac Soc.) 2012;98:947–955. doi: 10.1136/heartjnl-2011-301329.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/heartjnl-2011-301329</ArticleId><ArticleId IdType="pubmed">22626903</ArticleId></ArticleIdList></Reference><Reference><Citation>Merghani A, Malhotra A, Sharma S. The U-shaped relationship between exercise and cardiac morbidity. Trends Cardiovas. Med. 2016;26:232–240. doi: 10.1016/j.tcm.2015.06.005.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.tcm.2015.06.005</ArticleId><ArticleId IdType="pubmed">26187713</ArticleId></ArticleIdList></Reference><Reference><Citation>La Gerche A, et al. Disproportionate exercise load and remodeling of the athlete's right ventricle. Med. Sci. Sports Exerc. 2011;43:974–981. doi: 10.1249/MSS.0b013e31820607a3.</Citation><ArticleIdList><ArticleId IdType="doi">10.1249/MSS.0b013e31820607a3</ArticleId><ArticleId IdType="pubmed">21085033</ArticleId></ArticleIdList></Reference><Reference><Citation>Simpson RJ, et al. Can exercise affect immune function to increase susceptibility to infection? Exerc. Immunol. Rev. 2020;26:8–22.</Citation><ArticleIdList><ArticleId IdType="pubmed">32139352</ArticleId></ArticleIdList></Reference><Reference><Citation>Favere K, et al. A systematic literature review on the effects of exercise on human Toll-like receptor expression. Exerc. Immunol. Rev. 2021;27:84–124.</Citation><ArticleIdList><ArticleId IdType="pubmed">33965901</ArticleId></ArticleIdList></Reference><Reference><Citation>Pelliccia A, et al. 2020 ESC Guidelines on sports cardiology and exercise in patients with cardiovascular disease. Eur. Heart J. 2021;42:17–96. doi: 10.1093/eurheartj/ehaa605.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/eurheartj/ehaa605</ArticleId><ArticleId IdType="pubmed">32860412</ArticleId></ArticleIdList></Reference><Reference><Citation>Federici EE, Lerner AM, Abelmann WH. Observations on the course of coxsackie A-9 myocarditis in C3H mice. Proc. Soc. Exp. Biol. Med. 1963;112:672–676. doi: 10.3181/00379727-112-28136.</Citation><ArticleIdList><ArticleId IdType="doi">10.3181/00379727-112-28136</ArticleId><ArticleId IdType="pubmed">13944662</ArticleId></ArticleIdList></Reference><Reference><Citation>Tilles JG, et al. Effects of exercise on coxsackie A9 myocarditis in adult mice. Proc. Soc. Exp. Biol. Med. 1964;117:777–782. doi: 10.3181/00379727-117-29696.</Citation><ArticleIdList><ArticleId IdType="doi">10.3181/00379727-117-29696</ArticleId><ArticleId IdType="pubmed">14244953</ArticleId></ArticleIdList></Reference><Reference><Citation>Gatmaitan BG, Chason JL, Lerner AM. Augmentation of the virulence of murine coxsackie-virus B-3 myocardiopathy by exercise. J. Exp. Med. 1970;131:1121–1136. doi: 10.1084/jem.131.6.1121.</Citation><ArticleIdList><ArticleId IdType="doi">10.1084/jem.131.6.1121</ArticleId><ArticleId IdType="pmc">PMC2138852</ArticleId><ArticleId IdType="pubmed">4246139</ArticleId></ArticleIdList></Reference><Reference><Citation>Kiel RJ, Smith FE, Chason J, Khatib R, Reyes MP. Coxsackievirus B3 myocarditis in C3H/HeJ mice: Description of an inbred model and the effect of exercise on virulence. Eur. J. Epidemiol. 1989;5:348–350. doi: 10.1007/BF00144836.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/BF00144836</ArticleId><ArticleId IdType="pubmed">2551723</ArticleId></ArticleIdList></Reference><Reference><Citation>Reyes MP, Ho KL, Smith F, Lerner AM. A mouse model of dilated-type cardiomyopathy due to coxsackievirus-B3. J. Infect. Dis. 1981;144:232–236. doi: 10.1093/infdis/144.3.232.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/infdis/144.3.232</ArticleId><ArticleId IdType="pubmed">6268714</ArticleId></ArticleIdList></Reference><Reference><Citation>Ilback NG, Fohlman J, Friman G. Exercise in coxsackie B3 myocarditis: effects on heart lymphocyte subpopulations and the inflammatory reaction. Am. Heart J. 1989;117:1298–1302. doi: 10.1016/0002-8703(89)90409-2.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/0002-8703(89)90409-2</ArticleId><ArticleId IdType="pubmed">2543197</ArticleId></ArticleIdList></Reference><Reference><Citation>Cabinian AE, et al. Modification of exercise-aggravated coxsackievirus-B3 murine myocarditis by lymphocyte-T suppression in an inbred model. J. Lab. Clin. Med. 1990;115:454–462.</Citation><ArticleIdList><ArticleId IdType="pubmed">2157783</ArticleId></ArticleIdList></Reference><Reference><Citation>Poole DC, et al. Guidelines for animal exercise and training protocols for cardiovascular studies. Am. J. Physiol. Heart Circ. Physiol. 2020;318:H1100–H1138. doi: 10.1152/ajpheart.00697.2019.</Citation><ArticleIdList><ArticleId IdType="doi">10.1152/ajpheart.00697.2019</ArticleId><ArticleId IdType="pmc">PMC7254566</ArticleId><ArticleId IdType="pubmed">32196357</ArticleId></ArticleIdList></Reference><Reference><Citation>Dougherty JP, Springer DA, Gershengorn MC. The treadmill fatigue test: A simple, high-throughput assay of fatigue-like behavior for the mouse. J. Vis. Exp. 2016 doi: 10.3791/54052.</Citation><ArticleIdList><ArticleId IdType="doi">10.3791/54052</ArticleId><ArticleId IdType="pmc">PMC4927751</ArticleId><ArticleId IdType="pubmed">27286034</ArticleId></ArticleIdList></Reference><Reference><Citation>Schefer V, Talan MI. Oxygen consumption in adult and AGED C57BL/6J mice during acute treadmill exercise of different intensity. Exp. Gerontol. 1996;31:387–392. doi: 10.1016/0531-5565(95)02032-2.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/0531-5565(95)02032-2</ArticleId><ArticleId IdType="pubmed">9415121</ArticleId></ArticleIdList></Reference><Reference><Citation>Hastings MH, et al. Animal models of exercise from rodents to pythons. Circ. Res. 2022;130:1994–2014. doi: 10.1161/CIRCRESAHA.122.320247.</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/CIRCRESAHA.122.320247</ArticleId><ArticleId IdType="pmc">PMC9202075</ArticleId><ArticleId IdType="pubmed">35679366</ArticleId></ArticleIdList></Reference><Reference><Citation>Favere K, et al. Cardiac electrophysiology studies in mice via the transjugular route: A comprehensive practical guide. Am. J. Physiol. Heart Circ. Physiol. 2022;323:H763–H773. doi: 10.1152/ajpheart.00337.2022.</Citation><ArticleIdList><ArticleId IdType="doi">10.1152/ajpheart.00337.2022</ArticleId><ArticleId IdType="pubmed">36018757</ArticleId></ArticleIdList></Reference><Reference><Citation>Maheras KJ, Gow A. Increased anesthesia time using 2,2,2-tribromoethanol-chloral hydrate with low impact on mouse psychoacoustics. J. Neurosci. Methods. 2013;219:61–69. doi: 10.1016/j.jneumeth.2013.07.004.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jneumeth.2013.07.004</ArticleId><ArticleId IdType="pmc">PMC3818901</ArticleId><ArticleId IdType="pubmed">23856212</ArticleId></ArticleIdList></Reference><Reference><Citation>Hart CY, Burnett JC, Jr, Redfield MM. Effects of avertin versus xylazine-ketamine anesthesia on cardiac function in normal mice. Am. J. Physiol. Heart Circ. Physiol. 2001;281:H1938–1945. doi: 10.1152/ajpheart.2001.281.5.H1938.</Citation><ArticleIdList><ArticleId IdType="doi">10.1152/ajpheart.2001.281.5.H1938</ArticleId><ArticleId IdType="pubmed">11668054</ArticleId></ArticleIdList></Reference><Reference><Citation>Bedossa P, et al. Histopathological algorithm and scoring system for evaluation of liver lesions in morbidly obese patients. Hepatology. 2012;56:1751–1759. doi: 10.1002/hep.25889.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/hep.25889</ArticleId><ArticleId IdType="pubmed">22707395</ArticleId></ArticleIdList></Reference><Reference><Citation>Kim MY, et al. Histological subclassification of cirrhosis using the Laennec fibrosis scoring system correlates with clinical stage and grade of portal hypertension. J. Hepatol. 2011;55:1004–1009. doi: 10.1016/j.jhep.2011.02.012.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jhep.2011.02.012</ArticleId><ArticleId IdType="pubmed">21354227</ArticleId></ArticleIdList></Reference><Reference><Citation>Bankhead P, et al. QuPath: Open source software for digital pathology image analysis. Sci. Rep. 2017;7:16878. doi: 10.1038/s41598-017-17204-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41598-017-17204-5</ArticleId><ArticleId IdType="pmc">PMC5715110</ArticleId><ArticleId IdType="pubmed">29203879</ArticleId></ArticleIdList></Reference><Reference><Citation>Basso C, Calabrese F, Angelini A, Carturan E, Thiene G. Classification and histological, immunohistochemical, and molecular diagnosis of inflammatory myocardial disease. Heart Fail. Rev. 2013;18:673–681. doi: 10.1007/s10741-012-9355-6.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s10741-012-9355-6</ArticleId><ArticleId IdType="pubmed">23096264</ArticleId></ArticleIdList></Reference><Reference><Citation>Maisch B. Cardio-immunology of myocarditis: Focus on immune mechanisms and treatment options. Front. Cardiovasc. Med. 2019;6:48. doi: 10.3389/fcvm.2019.00048.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fcvm.2019.00048</ArticleId><ArticleId IdType="pmc">PMC6473396</ArticleId><ArticleId IdType="pubmed">31032264</ArticleId></ArticleIdList></Reference><Reference><Citation>De Bono JP, Adlam D, Paterson DJ, Channon KM. Novel quantitative phenotypes of exercise training in mouse models. Am. J. Physiol. Regul. Integr. Comp. Physiol. 2006;290:R926–934. doi: 10.1152/ajpregu.00694.2005.</Citation><ArticleIdList><ArticleId IdType="doi">10.1152/ajpregu.00694.2005</ArticleId><ArticleId IdType="pubmed">16339385</ArticleId></ArticleIdList></Reference><Reference><Citation>Perrino C, et al. Cardiovascular effects of treadmill exercise in physiological and pathological preclinical settings. Am. J. Physiol. Heart Circ. Physiol. 2011;300:H1983–1989. doi: 10.1152/ajpheart.00784.2010.</Citation><ArticleIdList><ArticleId IdType="doi">10.1152/ajpheart.00784.2010</ArticleId><ArticleId IdType="pubmed">21490325</ArticleId></ArticleIdList></Reference><Reference><Citation>Feng R, et al. A systematic comparison of exercise training protocols on animal models of cardiovascular capacity. Life Sci. 2019;217:128–140. doi: 10.1016/j.lfs.2018.12.001.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.lfs.2018.12.001</ArticleId><ArticleId IdType="pmc">PMC6320317</ArticleId><ArticleId IdType="pubmed">30517851</ArticleId></ArticleIdList></Reference><Reference><Citation>Gibb AA, et al. FVB/NJ mice are a useful model for examining cardiac adaptations to treadmill exercise. Front. Physiol. 2016;7:636. doi: 10.3389/fphys.2016.00636.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fphys.2016.00636</ArticleId><ArticleId IdType="pmc">PMC5174104</ArticleId><ArticleId IdType="pubmed">28066267</ArticleId></ArticleIdList></Reference><Reference><Citation>de Araujo RB, Chacon-Mikahil MPT, Lord JM, Sardeli AV. Exercise effect on symptom severity, morbidity and mortality in viral infections: A systematic review and meta-analysis. Exerc. Immunol. Rev. 2022;28:133–140.</Citation><ArticleIdList><ArticleId IdType="pubmed">35913495</ArticleId></ArticleIdList></Reference><Reference><Citation>Burnley M, Bearden SE, Jones AM. Polarized training is not optimal for endurance athletes: Response to foster and colleagues. Med. Sci. Sports Exerc. 2022;54:1038–1040. doi: 10.1249/MSS.0000000000002924.</Citation><ArticleIdList><ArticleId IdType="doi">10.1249/MSS.0000000000002924</ArticleId><ArticleId IdType="pubmed">35576139</ArticleId></ArticleIdList></Reference><Reference><Citation>Corsten MF, Schroen B, Heymans S. Inflammation in viral myocarditis: Friend or foe? Trends Mol. Med. 2012;18:426–437. doi: 10.1016/j.molmed.2012.05.005.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.molmed.2012.05.005</ArticleId><ArticleId IdType="pubmed">22726657</ArticleId></ArticleIdList></Reference><Reference><Citation>Silverio JC, et al. CD8+ T-cells expressing interferon gamma or perforin play antagonistic roles in heart injury in experimental Trypanosoma cruzi-elicited cardiomyopathy. PLoS Pathog. 2012;8:e1002645. doi: 10.1371/journal.ppat.1002645.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.ppat.1002645</ArticleId><ArticleId IdType="pmc">PMC3330123</ArticleId><ArticleId IdType="pubmed">22532799</ArticleId></ArticleIdList></Reference><Reference><Citation>Patel B, et al. CCR2(+) monocyte-derived infiltrating macrophages are required for adverse cardiac remodeling during pressure overload. JACC Basic Transl. Sci. 2018;3:230–244. doi: 10.1016/j.jacbts.2017.12.006.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jacbts.2017.12.006</ArticleId><ArticleId IdType="pmc">PMC6059350</ArticleId><ArticleId IdType="pubmed">30062209</ArticleId></ArticleIdList></Reference><Reference><Citation>Becher PM, et al. Cardiac function remains impaired despite reversible cardiac remodeling after acute experimental viral myocarditis. J. Immunol. Res. 2017;2017:6590609. doi: 10.1155/2017/6590609.</Citation><ArticleIdList><ArticleId IdType="doi">10.1155/2017/6590609</ArticleId><ArticleId IdType="pmc">PMC5352897</ArticleId><ArticleId IdType="pubmed">28352641</ArticleId></ArticleIdList></Reference><Reference><Citation>Taylor LA, et al. Host gene regulation during coxsackievirus B3 infection in mice: Assessment by microarrays. Circ. Res. 2000;87:328–334. doi: 10.1161/01.res.87.4.328.</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/01.res.87.4.328</ArticleId><ArticleId IdType="pubmed">10948068</ArticleId></ArticleIdList></Reference><Reference><Citation>Favere K, et al. The natural history of CVB3 myocarditis in C57BL/6J mice: an extended in-depth characterization. Cardiovasc. Pathol. 2024 doi: 10.1016/j.carpath.2024.107652.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.carpath.2024.107652</ArticleId><ArticleId IdType="pubmed">38750778</ArticleId></ArticleIdList></Reference><Reference><Citation>Etoh T, et al. Myocardial and interstitial matrix metalloproteinase activity after acute myocardial infarction in pigs. Am. J. Physiol. Heart Circ. Physiol. 2001;281:H987–994. doi: 10.1152/ajpheart.2001.281.3.H987.</Citation><ArticleIdList><ArticleId IdType="doi">10.1152/ajpheart.2001.281.3.H987</ArticleId><ArticleId IdType="pubmed">11514263</ArticleId></ArticleIdList></Reference><Reference><Citation>Coronado MJ, et al. Testosterone and interleukin-1beta increase cardiac remodeling during coxsackievirus B3 myocarditis via serpin A 3n. Am. J. Physiol. Heart Circ. Physiol. 2012;302:H1726–1736. doi: 10.1152/ajpheart.00783.2011.</Citation><ArticleIdList><ArticleId IdType="doi">10.1152/ajpheart.00783.2011</ArticleId><ArticleId IdType="pmc">PMC3330806</ArticleId><ArticleId IdType="pubmed">22328081</ArticleId></ArticleIdList></Reference><Reference><Citation>de Lucia C, Wallner M, Corradi D, Pironti G. Editorial: Cardiac fibrosis, from lineage tracing to therapeutic application. Front. Physiol. 2020;11:641771. doi: 10.3389/fphys.2020.641771.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fphys.2020.641771</ArticleId><ArticleId IdType="pmc">PMC7855971</ArticleId><ArticleId IdType="pubmed">33551854</ArticleId></ArticleIdList></Reference><Reference><Citation>Travers JG, Kamal FA, Robbins J, Yutzey KE, Blaxall BC. Cardiac fibrosis: The fibroblast awakens. Circ. Res. 2016;118:1021–1040. doi: 10.1161/CIRCRESAHA.115.306565.</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/CIRCRESAHA.115.306565</ArticleId><ArticleId IdType="pmc">PMC4800485</ArticleId><ArticleId IdType="pubmed">26987915</ArticleId></ArticleIdList></Reference><Reference><Citation>Talman V, Ruskoaho H. Cardiac fibrosis in myocardial infarction-from repair and remodeling to regeneration. Cell Tissue Res. 2016;365:563–581. doi: 10.1007/s00441-016-2431-9.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00441-016-2431-9</ArticleId><ArticleId IdType="pmc">PMC5010608</ArticleId><ArticleId IdType="pubmed">27324127</ArticleId></ArticleIdList></Reference><Reference><Citation>James CA, et al. Exercise increases age-related penetrance and arrhythmic risk in arrhythmogenic right ventricular dysplasia/cardiomyopathy-associated desmosomal mutation carriers. J. Am. Coll. Cardiol. 2013;62:1290–1297. doi: 10.1016/j.jacc.2013.06.033.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jacc.2013.06.033</ArticleId><ArticleId IdType="pmc">PMC3809992</ArticleId><ArticleId IdType="pubmed">23871885</ArticleId></ArticleIdList></Reference><Reference><Citation>Benito B, et al. Cardiac arrhythmogenic remodeling in a rat model of long-term intensive exercise training. Circulation. 2011;123:13–22. doi: 10.1161/CIRCULATIONAHA.110.938282.</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/CIRCULATIONAHA.110.938282</ArticleId><ArticleId IdType="pubmed">21173356</ArticleId></ArticleIdList></Reference><Reference><Citation>van de Schoor FR, et al. Myocardial fibrosis in athletes. Mayo Clin. Proc. 2016;91:1617–1631. doi: 10.1016/j.mayocp.2016.07.012.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.mayocp.2016.07.012</ArticleId><ArticleId IdType="pubmed">27720455</ArticleId></ArticleIdList></Reference><Reference><Citation>Caforio AL, et al. A prospective study of biopsy-proven myocarditis: Prognostic relevance of clinical and aetiopathogenetic features at diagnosis. Eur. Heart J. 2007;28:1326–1333. doi: 10.1093/eurheartj/ehm076.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/eurheartj/ehm076</ArticleId><ArticleId IdType="pubmed">17493945</ArticleId></ArticleIdList></Reference><Reference><Citation>Magnani JW, Danik HJ, Dec GW, Jr, DiSalvo TG. Survival in biopsy-proven myocarditis: A long-term retrospective analysis of the histopathologic, clinical, and hemodynamic predictors. Am. Heart J. 2006;151:463–470. doi: 10.1016/j.ahj.2005.03.037.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ahj.2005.03.037</ArticleId><ArticleId IdType="pubmed">16442915</ArticleId></ArticleIdList></Reference><Reference><Citation>Favere K, et al. Toll-like receptors: Are they taking a toll on the heart in viral myocarditis? Viruses. 2021 doi: 10.3390/v13061003.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/v13061003</ArticleId><ArticleId IdType="pmc">PMC8227433</ArticleId><ArticleId IdType="pubmed">34072044</ArticleId></ArticleIdList></Reference><Reference><Citation>Meyerholz DK, Beck AP. Fundamental concepts for semiquantitative tissue scoring in translational research. ILAR J. 2018;59:13–17. doi: 10.1093/ilar/ily025.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/ilar/ily025</ArticleId><ArticleId IdType="pmc">PMC6927897</ArticleId><ArticleId IdType="pubmed">30715381</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle>